Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Mar 15, 2016; 8(3): 248-257
Published online Mar 15, 2016. doi: 10.4251/wjgo.v8.i3.248
Published online Mar 15, 2016. doi: 10.4251/wjgo.v8.i3.248
Table 1 Standard adjuvant therapy
| Gemcitabine 1000 mg/m2i.v. 30 min | d1, 8, 15, q29 |
| 6 cycles | |
| 5-flourouracil 425 mg/m2i.v. Bolus | d1-5, q29 |
| Folinic acid 20 mg/m2i.v. Bolus | 6 cycles |
- Citation: Sinn M, Bahra M, Denecke T, Travis S, Pelzer U, Riess H. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival. World J Gastrointest Oncol 2016; 8(3): 248-257
- URL: https://www.wjgnet.com/1948-5204/full/v8/i3/248.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i3.248